$KPTI
看空2022-03-01各周期结果✓ 命中-17.6%
1d
✓ -1.2%
5d
✗ +3.4%
21d
✓ -17.6%
原帖
TexMex · 2022-03-01
$KPTI Karyopharm Provides U.S. Regulatory Update on Selinexor in Advanced or Recurrent Endometrial Cancer New study coming. Current study unlikely to support an sNDA
在 X 查看 ↗